Literature DB >> 19729485

Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy.

Akane Kizu1, Damian Medici, Raghu Kalluri.   

Abstract

This Commentary provides perspective on epithelial-mesenchymal transition in diabetic nephropathy.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19729485      PMCID： PMC2751533          DOI： 10.2353/ajpath.2009.090698

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


  17 in total

Review 1.  The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond.

Authors:  Vibha N Lama; Sem H Phan
Journal:  Proc Am Thorac Soc       Date:  2006-06

2.  Structural changes in renal arterioles in Type I diabetic patients.

Authors:  R Østerby; A Hartmann; H-J Bangstad
Journal:  Diabetologia       Date:  2002-04       Impact factor: 10.122

Review 3.  Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy.

Authors:  N K Hollenberg; L Raij
Journal:  Arch Intern Med       Date:  1993-11-08

Review 4.  Epithelial-mesenchymal transition and its implications for fibrosis.

Authors:  Raghu Kalluri; Eric G Neilson
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

5.  Structural-functional relationships in diabetic nephropathy.

Authors:  S M Mauer; M W Steffes; E N Ellis; D E Sutherland; D M Brown; F C Goetz
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

6.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis.

Authors:  Elisabeth M Zeisberg; Oleg Tarnavski; Michael Zeisberg; Adam L Dorfman; Julie R McMullen; Erika Gustafsson; Anil Chandraker; Xueli Yuan; William T Pu; Anita B Roberts; Eric G Neilson; Mohamed H Sayegh; Seigo Izumo; Raghu Kalluri
Journal:  Nat Med       Date:  2007-07-29       Impact factor: 53.440

Review 7.  The role of epithelial-to-mesenchymal transition in renal fibrosis.

Authors:  Michael Zeisberg; Raghu Kalluri
Journal:  J Mol Med (Berl)       Date:  2004-01-30       Impact factor: 4.599

8.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

Authors:  E J Lewis; L G Hunsicker; R P Bain; R D Rohde
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

9.  Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice.

Authors:  Jinhua Li; Xinli Qu; John F Bertram
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

10.  TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes.

Authors:  L P Sanford; I Ormsby; A C Gittenberger-de Groot; H Sariola; R Friedman; G P Boivin; E L Cardell; T Doetschman
Journal:  Development       Date:  1997-07       Impact factor: 6.868
View more
  45 in total

1.  Protein kinase Cδ and c-Abl kinase are required for transforming growth factor β induction of endothelial-mesenchymal transition in vitro.

Authors:  Zhaodong Li; Sergio A Jimenez
Journal:  Arthritis Rheum       Date:  2011-08

Review 2.  "Venopathy" at work: recasting neointimal hyperplasia in a new light.

Authors:  Alexander S Yevzlin; Micah R Chan; Yolanda T Becker; Prabir Roy-Chaudhury; Timmy Lee; Bryan N Becker
Journal:  Transl Res       Date:  2010-08-13       Impact factor: 7.012

3.  Isoform-specific effects of transforming growth factor β on endothelial-to-mesenchymal transition.

Authors:  Harika Sabbineni; Arti Verma; Payaningal R Somanath
Journal:  J Cell Physiol       Date:  2018-06-01       Impact factor: 6.384

Review 4.  Vasculopathy in scleroderma.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

Review 5.  Wounds that will not heal: pervasive cellular reprogramming in cancer.

Authors:  Jung S Byun; Kevin Gardner
Journal:  Am J Pathol       Date:  2013-02-22       Impact factor: 4.307

6.  Shift in Focus-To Explore the Role of the Endothelium in Kidney Disease.

Authors:  Ilse Daehn
Journal:  HSOA J Nephrol Ren Ther       Date:  2016-03-10

Review 7.  More than just an enzyme: Dipeptidyl peptidase-4 (DPP-4) and its association with diabetic kidney remodelling.

Authors:  Shreyasi Gupta; Utpal Sen
Journal:  Pharmacol Res       Date:  2019-08-08       Impact factor: 7.658

Review 8.  Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment.

Authors:  Maurizio Salvadori; Giuseppina Rosso; Elisabetta Bertoni
Journal:  World J Transplant       Date:  2015-06-24

9.  Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice.

Authors:  Takashi Taniguchi; Yoshihide Asano; Kaname Akamata; Shinji Noda; Takehiro Takahashi; Yohei Ichimura; Tetsuo Toyama; Maria Trojanowska; Shinichi Sato
Journal:  Arthritis Rheumatol       Date:  2015-02       Impact factor: 10.995

10.  Deletion of cysteine-cysteine receptor 7 promotes fibrotic injury in experimental post-thrombotic vein wall remodeling.

Authors:  Adriana Laser; Megan Elfline; Cathy Luke; Dallas Slack; Anuj Shah; Vikram Sood; Barry Deatrick; Brendan McEvoy; Carson Ostra; Anthony Comerota; Steven Kunkel; Cory Hogaboam; Peter K Henke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-12-05       Impact factor: 8.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.